$LGND Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in LIGAND PHARMACEUTICALS INC.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in LIGAND PHARMACEUTICALS INC. Get notifications about new insider transactions in LIGAND PHARMACEUTICALS INC for free.
Page: < prev 1 ... 4 5 6 7 8 9 10 11 12 ... 15 next >
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Jun 05 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 11.98 | 700 | 8,386 | 285,036 | 284.3 K to 285 K (+0.25 %) |
Jun 04 2012 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
Jun 04 2012 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 12.02 | 2,000 | 24,040 | 17,425 | 15.4 K to 17.4 K (+12.97 %) |
Jun 04 2012 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Grant | A | 0.00 | 4,721 | 0 | 15,425 | 10.7 K to 15.4 K (+44.11 %) |
Jun 04 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
Jun 04 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Grant | A | 0.00 | 4,721 | 0 | 59,425 | 54.7 K to 59.4 K (+8.63 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 3,592 | 0 | 28,318 | 24.7 K to 28.3 K (+14.53 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Grant | A | 0.00 | 2,925 | 0 | 24,726 | 21.8 K to 24.7 K (+13.42 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 3,592 | 0 | 35,718 | 32.1 K to 35.7 K (+11.18 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Davis Todd C | Director | Grant | A | 0.00 | 2,925 | 0 | 32,126 | 29.2 K to 32.1 K (+10.02 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 3,592 | 0 | 33,615 | 30 K to 33.6 K (+11.96 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Grant | A | 0.00 | 2,925 | 0 | 30,023 | 27.1 K to 30 K (+10.79 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 1,796 | 0 | 21,535 | 19.7 K to 21.5 K (+9.10 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | LAMATTINA JOHN L | Director | Grant | A | 0.00 | 2,925 | 0 | 19,739 | 16.8 K to 19.7 K (+17.40 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Option Exercise | A | 12.53 | 7,335 | 91,908 | 7,335 | |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 3,592 | 0 | 36,222 | 32.6 K to 36.2 K (+11.01 %) |
May 31 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Grant | A | 0.00 | 2,925 | 0 | 32,630 | 29.7 K to 32.6 K (+9.85 %) |
May 25 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 11.62 | 21,200 | 246,344 | 41,583 | 62.8 K to 41.6 K (-33.77 %) |
May 25 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 11.62 | 76,167 | 885,061 | 331,396 | 407.6 K to 331.4 K (-18.69 %) |
May 25 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | S | 11.62 | 98,633 | 1,146,115 | 0 | 98.6 K to 0 (-100.00 %) |
May 25 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.62 | 23,900 | 277,718 | 264,661 | 240.8 K to 264.7 K (+9.93 %) |
May 25 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.62 | 172,100 | 1,999,802 | 972,100 | 800 K to 972.1 K (+21.51 %) |
May 24 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.39 | 1,249 | 14,221 | 29,705 | 28.5 K to 29.7 K (+4.39 %) |
May 24 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.37 | 31 | 352 | 28,456 | 28.4 K to 28.5 K (+0.11 %) |
May 24 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.35 | 20 | 227 | 28,425 | 28.4 K to 28.4 K (+0.07 %) |
May 24 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.35 | 100 | 1,135 | 28,405 | 28.3 K to 28.4 K (+0.35 %) |
May 24 2012 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.35 | 100 | 1,135 | 28,305 | 28.2 K to 28.3 K (+0.35 %) |
May 08 2012 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Buy | P | 12.04 | 1,000 | 12,040 | 108,275 | 107.3 K to 108.3 K (+0.93 %) |
Mar 08 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 15.77 | 106 | 1,671 | 17,328 | 17.4 K to 17.3 K (-0.61 %) |
Mar 08 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Sell | S | 15.76 | 3,500 | 55,160 | 17,434 | 20.9 K to 17.4 K (-16.72 %) |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 14.47 | 15,000 | 217,050 | 59,235 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 14.47 | 44,235 | 640,080 | 44,235 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Option Exercise | A | 14.47 | 30,765 | 445,170 | 30,765 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | DeSilva Nishan M | VP, Corporate Devel ... | Grant | A | 0.00 | 10,000 | 0 | 10,000 | 0 to 10 K |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Option Exercise | A | 14.47 | 8,134 | 117,699 | 8,134 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Option Exercise | A | 14.47 | 16,866 | 244,051 | 16,866 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Kazmi Syed | VP, Bus. Dev. & Str ... | Grant | A | 0.00 | 4,000 | 0 | 18,230 | 14.2 K to 18.2 K (+28.11 %) |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 14.47 | 9,870 | 142,819 | 9,870 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Option Exercise | A | 14.47 | 15,130 | 218,931 | 15,130 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Grant | A | 0.00 | 5,000 | 0 | 20,934 | 15.9 K to 20.9 K (+31.38 %) |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Option Exercise | A | 14.47 | 23,204 | 335,762 | 23,204 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Option Exercise | A | 14.47 | 11,796 | 170,688 | 11,796 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | Sharp John P | VP Finance and CFO | Grant | A | 0.00 | 5,000 | 0 | 21,666 | 16.7 K to 21.7 K (+30.00 %) |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Option Exercise | A | 14.47 | 60,000 | 868,200 | 60,000 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Grant | A | 0.00 | 10,000 | 0 | 36,250 | 26.3 K to 36.3 K (+38.10 %) |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Option Exercise | A | 14.47 | 175,000 | 2,532,250 | 175,000 | |
Feb 13 2012 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Grant | A | 0.00 | 18,000 | 0 | 107,275 | 89.3 K to 107.3 K (+20.16 %) |
Jan 06 2012 | LGND | LIGAND PHARMACEUTI ... | HIGGINS JOHN L | President & CEO | Buy | J | 10.09 | 210 | 2,119 | 89,275 | 89.1 K to 89.3 K (+0.24 %) |
Jan 06 2012 | LGND | LIGAND PHARMACEUTI ... | FOEHR MATTHEW W | EVP and COO | Buy | J | 10.09 | 1,250 | 12,612 | 26,250 | 25 K to 26.3 K (+5.00 %) |
Jan 04 2012 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Sell | J | 0.00 | 28,300 | 0 | 0 | 28.3 K to 0 (-100.00 %) |
Jan 06 2012 | LGND | LIGAND PHARMACEUTI ... | Berkman Charles S | VP, Gen. Counsel & ... | Buy | J | 10.09 | 1,238 | 12,491 | 15,934 | 14.7 K to 15.9 K (+8.42 %) |
Nov 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.59 | 280,100 | 2,966,259 | 2,068,326 | 1.8 M to 2.1 M (+15.66 %) |
Nov 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.59 | 60,100 | 636,459 | 444,151 | 384.1 K to 444.2 K (+15.65 %) |
Nov 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 10.59 | 98,171 | 1,039,631 | 725,036 | 626.9 K to 725 K (+15.66 %) |
Nov 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.01 | 46,426 | 510,965 | 1,788,226 | 1.7 M to 1.8 M (+2.67 %) |
Nov 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.01 | 9,951 | 109,521 | 384,051 | 374.1 K to 384.1 K (+2.66 %) |
Nov 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.01 | 16,292 | 179,310 | 626,865 | 610.6 K to 626.9 K (+2.67 %) |
Nov 14 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Buy | P | 11.50 | 1,000 | 11,500 | 12,704 | 11.7 K to 12.7 K (+8.54 %) |
Nov 14 2011 | LGND | LIGAND PHARMACEUTI ... | Sabba Stephen L | Director | Buy | P | 11.69 | 1,000 | 11,690 | 11,704 | 10.7 K to 11.7 K (+9.34 %) |
Nov 14 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.58 | 4,000 | 46,320 | 54,704 | 50.7 K to 54.7 K (+7.89 %) |
Nov 14 2011 | LGND | LIGAND PHARMACEUTI ... | KOZARICH JOHN W | Director | Buy | P | 11.79 | 1,000 | 11,787 | 27,098 | 26.1 K to 27.1 K (+3.83 %) |
Nov 10 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 10.90 | 1,000 | 10,900 | 5,025 | 4 K to 5 K (+24.84 %) |
Nov 10 2011 | LGND | LIGAND PHARMACEUTI ... | Aryeh Jason | Director | Buy | P | 11.01 | 1,000 | 11,010 | 284,336 | 283.3 K to 284.3 K (+0.35 %) |
Oct 28 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.91 | 3,800 | 52,866 | 1,741,800 | 1.7 M to 1.7 M (+0.22 %) |
Oct 28 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.91 | 900 | 12,521 | 374,100 | 373.2 K to 374.1 K (+0.24 %) |
Oct 28 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.91 | 1,320 | 18,364 | 610,573 | 609.3 K to 610.6 K (+0.22 %) |
Nov 10 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.11 | 1,700 | 18,887 | 28,205 | 26.5 K to 28.2 K (+6.41 %) |
Nov 10 2011 | LGND | LIGAND PHARMACEUTI ... | Patel Sunil | Director | Buy | P | 11.11 | 800 | 8,887 | 26,505 | 25.7 K to 26.5 K (+3.11 %) |
Oct 25 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 3,000 | 41,780 | 1,738,000 | 1.7 M to 1.7 M (+0.17 %) |
Oct 25 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 600 | 8,356 | 373,200 | 372.6 K to 373.2 K (+0.16 %) |
Oct 25 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 1,000 | 13,927 | 609,253 | 608.3 K to 609.3 K (+0.16 %) |
Oct 20 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 7,600 | 105,895 | 1,735,000 | 1.7 M to 1.7 M (+0.44 %) |
Oct 20 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 1,600 | 22,294 | 372,600 | 371 K to 372.6 K (+0.43 %) |
Oct 20 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.93 | 2,700 | 37,620 | 608,253 | 605.6 K to 608.3 K (+0.45 %) |
Oct 20 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.73 | 1,400 | 19,228 | 1,727,400 | 1.7 M to 1.7 M (+0.08 %) |
Oct 20 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.73 | 300 | 4,120 | 371,000 | 370.7 K to 371 K (+0.08 %) |
Oct 20 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.73 | 500 | 6,867 | 605,553 | 605.1 K to 605.6 K (+0.08 %) |
Oct 14 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.55 | 14,238 | 192,953 | 1,726,000 | 1.7 M to 1.7 M (+0.83 %) |
Oct 14 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.55 | 3,020 | 40,927 | 370,700 | 367.7 K to 370.7 K (+0.82 %) |
Oct 14 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.55 | 4,995 | 67,692 | 605,053 | 600.1 K to 605.1 K (+0.83 %) |
Oct 14 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.69 | 36,200 | 495,614 | 1,711,762 | 1.7 M to 1.7 M (+2.16 %) |
Oct 14 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.69 | 5,600 | 76,670 | 367,680 | 362.1 K to 367.7 K (+1.55 %) |
Oct 14 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 13.69 | 11,300 | 154,708 | 600,058 | 588.8 K to 600.1 K (+1.92 %) |
Oct 06 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 12.78 | 4,300 | 54,933 | 362,080 | 357.8 K to 362.1 K (+1.20 %) |
Oct 06 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 12.78 | 4,000 | 51,100 | 1,675,562 | 1.7 M to 1.7 M (+0.24 %) |
Oct 06 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 12.78 | 6,100 | 77,928 | 588,758 | 582.7 K to 588.8 K (+1.05 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.21 | 5,300 | 75,313 | 402,843 | 397.5 K to 402.8 K (+1.33 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.21 | 1,200 | 17,052 | 97,033 | 95.8 K to 97 K (+1.25 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.21 | 3,100 | 44,051 | 237,361 | 234.3 K to 237.4 K (+1.32 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.21 | 10,400 | 147,784 | 787,780 | 777.4 K to 787.8 K (+1.34 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.54 | 11,159 | 139,934 | 397,543 | 386.4 K to 397.5 K (+2.89 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.54 | 2,600 | 32,604 | 95,833 | 93.2 K to 95.8 K (+2.79 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.54 | 6,600 | 82,764 | 234,261 | 227.7 K to 234.3 K (+2.90 %) |
Aug 30 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.54 | 21,200 | 265,848 | 777,380 | 756.2 K to 777.4 K (+2.80 %) |
Sep 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 15.21 | 2,480 | 37,721 | 407,563 | 405.1 K to 407.6 K (+0.61 %) |
Sep 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 15.21 | 700 | 10,647 | 98,633 | 97.9 K to 98.6 K (+0.71 %) |
Sep 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 15.21 | 1,500 | 22,815 | 240,761 | 239.3 K to 240.8 K (+0.63 %) |
Sep 06 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 15.21 | 5,320 | 80,917 | 800,000 | 794.7 K to 800 K (+0.67 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.94 | 600 | 8,964 | 405,083 | 404.5 K to 405.1 K (+0.15 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.94 | 200 | 2,988 | 97,933 | 97.7 K to 97.9 K (+0.20 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.94 | 500 | 7,470 | 239,261 | 238.8 K to 239.3 K (+0.21 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.94 | 1,700 | 25,398 | 794,680 | 793 K to 794.7 K (+0.21 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.83 | 1,640 | 24,321 | 404,483 | 402.8 K to 404.5 K (+0.41 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.83 | 700 | 10,381 | 97,733 | 97 K to 97.7 K (+0.72 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.83 | 1,400 | 20,762 | 238,761 | 237.4 K to 238.8 K (+0.59 %) |
Sep 01 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 14.83 | 5,200 | 77,116 | 792,980 | 787.8 K to 793 K (+0.66 %) |
Aug 26 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.57 | 17,200 | 216,204 | 62,783 | 45.6 K to 62.8 K (+37.73 %) |
Aug 26 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.57 | 9,900 | 124,443 | 386,384 | 376.5 K to 386.4 K (+2.63 %) |
Aug 26 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.57 | 2,500 | 31,425 | 93,233 | 90.7 K to 93.2 K (+2.76 %) |
Aug 26 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.57 | 5,800 | 72,906 | 227,661 | 221.9 K to 227.7 K (+2.61 %) |
Aug 26 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.57 | 19,600 | 246,372 | 756,180 | 736.6 K to 756.2 K (+2.66 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.95 | 2,600 | 33,670 | 28,300 | 25.7 K to 28.3 K (+10.12 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.95 | 4,100 | 53,095 | 45,583 | 41.5 K to 45.6 K (+9.88 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.95 | 4,000 | 51,800 | 376,484 | 372.5 K to 376.5 K (+1.07 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.95 | 900 | 11,655 | 90,733 | 89.8 K to 90.7 K (+1.00 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.95 | 2,390 | 30,951 | 221,861 | 219.5 K to 221.9 K (+1.09 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.95 | 7,500 | 97,125 | 736,580 | 729.1 K to 736.6 K (+1.03 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.18 | 5,400 | 65,772 | 372,484 | 367.1 K to 372.5 K (+1.47 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.18 | 1,200 | 14,616 | 89,833 | 88.6 K to 89.8 K (+1.35 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.18 | 3,100 | 37,758 | 219,471 | 216.4 K to 219.5 K (+1.43 %) |
Aug 25 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.18 | 10,300 | 125,454 | 729,080 | 718.8 K to 729.1 K (+1.43 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.00 | 1,069 | 12,828 | 367,084 | 366 K to 367.1 K (+0.29 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.00 | 200 | 2,400 | 88,633 | 88.4 K to 88.6 K (+0.23 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.00 | 500 | 6,000 | 216,371 | 215.9 K to 216.4 K (+0.23 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.00 | 1,700 | 20,400 | 718,780 | 717.1 K to 718.8 K (+0.24 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.96 | 7,400 | 88,504 | 366,015 | 358.6 K to 366 K (+2.06 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.96 | 1,800 | 21,528 | 88,433 | 86.6 K to 88.4 K (+2.08 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.96 | 4,300 | 51,428 | 215,871 | 211.6 K to 215.9 K (+2.03 %) |
Aug 23 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.96 | 14,300 | 171,028 | 717,080 | 702.8 K to 717.1 K (+2.03 %) |
Aug 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.93 | 19,000 | 226,590 | 1,671,562 | 1.7 M to 1.7 M (+1.15 %) |
Aug 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.93 | 400 | 4,770 | 357,780 | 357.4 K to 357.8 K (+0.11 %) |
Aug 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.93 | 1,900 | 22,659 | 582,658 | 580.8 K to 582.7 K (+0.33 %) |
Aug 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.91 | 15,700 | 186,996 | 1,652,562 | 1.6 M to 1.7 M (+0.96 %) |
Aug 22 2011 | LGND | LIGAND PHARMACEUTI ... | BVF PARTNERS L P/IL | 10% Owner | Buy | P | 11.91 | 871 | 10,374 | 580,758 | 579.9 K to 580.8 K (+0.15 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.91 | 4,100 | 48,831 | 358,615 | 354.5 K to 358.6 K (+1.16 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.91 | 1,000 | 11,910 | 86,633 | 85.6 K to 86.6 K (+1.17 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.91 | 2,500 | 29,775 | 211,571 | 209.1 K to 211.6 K (+1.20 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.91 | 8,400 | 100,044 | 702,780 | 694.4 K to 702.8 K (+1.21 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.35 | 2,133 | 26,343 | 354,515 | 352.4 K to 354.5 K (+0.61 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.35 | 600 | 7,410 | 85,633 | 85 K to 85.6 K (+0.71 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.35 | 1,200 | 14,820 | 209,071 | 207.9 K to 209.1 K (+0.58 %) |
Aug 19 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 12.35 | 4,200 | 51,870 | 694,380 | 690.2 K to 694.4 K (+0.61 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.97 | 1,200 | 14,364 | 352,382 | 351.2 K to 352.4 K (+0.34 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.97 | 300 | 3,591 | 85,033 | 84.7 K to 85 K (+0.35 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.97 | 700 | 8,379 | 207,871 | 207.2 K to 207.9 K (+0.34 %) |
Aug 15 2011 | LGND | LIGAND PHARMACEUTI ... | KNOTT DAVID M | Director | Buy | P | 11.97 | 2,400 | 28,728 | 690,180 | 687.8 K to 690.2 K (+0.35 %) |